25 XP   0   0   10

MedCap AB (publ)
Buy, Hold or Sell?

Let's analyse Medcap together

PenkeI guess you are interested in MedCap AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MedCap AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MedCap AB (publ)

I send you an email if I find something interesting about MedCap AB (publ).

Quick analysis of Medcap (30 sec.)










What can you expect buying and holding a share of Medcap? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr69.09
Expected worth in 1 year
kr80.18
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
kr11.09
Return On Investment
2.6%

For what price can you sell your share?

Current Price per Share
kr422.00
Expected price per share
kr330.00 - kr424.00
How sure are you?
50%

1. Valuation of Medcap (5 min.)




Live pricePrice per Share (EOD)

kr422.00

Intrinsic Value Per Share

kr92.37 - kr171.03

Total Value Per Share

kr161.46 - kr240.12

2. Growth of Medcap (5 min.)




Is Medcap growing?

Current yearPrevious yearGrowGrow %
How rich?$94.3m$73.2m$15.1m17.1%

How much money is Medcap making?

Current yearPrevious yearGrowGrow %
Making money$3.9m$2.7m$1.2m31.7%
Net Profit Margin10.7%10.6%--

How much money comes from the company's main activities?

3. Financial Health of Medcap (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Medcap? (5 min.)

Welcome investor! Medcap's management wants to use your money to grow the business. In return you get a share of Medcap.

What can you expect buying and holding a share of Medcap?

First you should know what it really means to hold a share of Medcap. And how you can make/lose money.

Speculation

The Price per Share of Medcap is kr422.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medcap.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medcap, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr69.09. Based on the TTM, the Book Value Change Per Share is kr2.77 per quarter. Based on the YOY, the Book Value Change Per Share is kr2.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medcap.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.380.1%0.270.1%0.180.0%0.160.0%0.090.0%
Usd Book Value Change Per Share0.270.1%0.250.1%0.250.1%0.230.1%0.130.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.270.1%0.250.1%0.250.1%0.230.1%0.130.0%
Usd Price Per Share31.02-26.10-17.67-17.80-10.20-
Price to Earnings Ratio20.17-26.54-26.34-34.03-80.96-
Price-to-Total Gains Ratio113.99-111.87-74.72-204.11-192.80-
Price to Book Ratio4.89-4.38-3.57-4.61-3.04-
Price-to-Total Gains Ratio113.99-111.87-74.72-204.11-192.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share38.7818
Number of shares25
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.250.23
Usd Total Gains Per Share0.250.23
Gains per Quarter (25 shares)6.375.81
Gains per Year (25 shares)25.4923.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10251502313
20514004636
30766507059
401029009382
501271150116105
601531400139128
701781650163151
802041900186174
902292150209197
1002552400232220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.04.00.090.0%54.07.00.088.5%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%34.06.00.085.0%49.010.02.080.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.061.00.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%34.06.00.085.0%49.010.02.080.3%

Fundamentals of Medcap

About MedCap AB (publ)

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK250 million ($23.49 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Fundamental data was last updated by Penke on 2024-04-23 00:43:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of MedCap AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medcap earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • A Net Profit Margin of 13.6% means that kr0.14 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MedCap AB (publ):

  • The MRQ is 13.6%. The company is making a huge profit. +2
  • The TTM is 10.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.6%TTM10.7%+2.9%
TTM10.7%YOY10.6%+0.1%
TTM10.7%5Y9.2%+1.5%
5Y9.2%10Y7.2%+2.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6%-12.4%+26.0%
TTM10.7%-20.4%+31.1%
YOY10.6%-14.8%+25.4%
5Y9.2%-21.3%+30.5%
10Y7.2%-25.0%+32.2%
1.1.2. Return on Assets

Shows how efficient Medcap is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • 3.7% Return on Assets means that Medcap generated kr0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MedCap AB (publ):

  • The MRQ is 3.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM2.7%+1.0%
TTM2.7%YOY2.3%+0.4%
TTM2.7%5Y2.0%+0.7%
5Y2.0%10Y1.2%+0.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%-4.1%+7.8%
TTM2.7%-4.7%+7.4%
YOY2.3%-4.8%+7.1%
5Y2.0%-4.0%+6.0%
10Y1.2%-5.2%+6.4%
1.1.3. Return on Equity

Shows how efficient Medcap is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • 6.1% Return on Equity means Medcap generated kr0.06 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MedCap AB (publ):

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM4.4%+1.6%
TTM4.4%YOY3.7%+0.8%
TTM4.4%5Y3.8%+0.6%
5Y3.8%10Y2.3%+1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-4.2%+10.3%
TTM4.4%-5.8%+10.2%
YOY3.7%-5.7%+9.4%
5Y3.8%-6.3%+10.1%
10Y2.3%-7.1%+9.4%

1.2. Operating Efficiency of MedCap AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medcap is operating .

  • Measures how much profit Medcap makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • An Operating Margin of 16.6% means the company generated kr0.17  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MedCap AB (publ):

  • The MRQ is 16.6%. The company is operating efficient. +1
  • The TTM is 14.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ16.6%TTM14.3%+2.4%
TTM14.3%YOY15.5%-1.2%
TTM14.3%5Y13.0%+1.2%
5Y13.0%10Y10.4%+2.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.6%-24.3%+40.9%
TTM14.3%-16.4%+30.7%
YOY15.5%-13.7%+29.2%
5Y13.0%-19.9%+32.9%
10Y10.4%-24.5%+34.9%
1.2.2. Operating Ratio

Measures how efficient Medcap is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are kr1.28 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of MedCap AB (publ):

  • The MRQ is 1.276. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.970. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.276TTM0.970+0.305
TTM0.970YOY0.862+0.108
TTM0.9705Y0.901+0.069
5Y0.90110Y0.915-0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2761.442-0.166
TTM0.9701.439-0.469
YOY0.8621.431-0.569
5Y0.9011.436-0.535
10Y0.9151.374-0.459

1.3. Liquidity of MedCap AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medcap is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.23 means the company has kr2.23 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of MedCap AB (publ):

  • The MRQ is 2.231. The company is able to pay all its short-term debts. +1
  • The TTM is 2.270. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.231TTM2.270-0.039
TTM2.270YOY2.177+0.094
TTM2.2705Y1.758+0.513
5Y1.75810Y1.589+0.168
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2312.726-0.495
TTM2.2702.732-0.462
YOY2.1773.510-1.333
5Y1.7583.617-1.859
10Y1.5893.499-1.910
1.3.2. Quick Ratio

Measures if Medcap is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • A Quick Ratio of 1.42 means the company can pay off kr1.42 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MedCap AB (publ):

  • The MRQ is 1.424. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.486. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.424TTM1.486-0.062
TTM1.486YOY1.427+0.059
TTM1.4865Y1.144+0.342
5Y1.14410Y0.798+0.347
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4241.491-0.067
TTM1.4861.633-0.147
YOY1.4272.113-0.686
5Y1.1442.295-1.151
10Y0.7982.255-1.457

1.4. Solvency of MedCap AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medcap assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medcap to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.38 means that Medcap assets are financed with 38.2% credit (debt) and the remaining percentage (100% - 38.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MedCap AB (publ):

  • The MRQ is 0.382. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.389. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.382TTM0.389-0.007
TTM0.389YOY0.372+0.018
TTM0.3895Y0.458-0.069
5Y0.45810Y0.489-0.031
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3820.389-0.007
TTM0.3890.386+0.003
YOY0.3720.335+0.037
5Y0.4580.442+0.016
10Y0.4890.461+0.028
1.4.2. Debt to Equity Ratio

Measures if Medcap is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medcap to the Medical Devices industry mean.
  • A Debt to Equity ratio of 62.1% means that company has kr0.62 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MedCap AB (publ):

  • The MRQ is 0.621. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.641. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.621TTM0.641-0.020
TTM0.641YOY0.595+0.046
TTM0.6415Y0.920-0.280
5Y0.92010Y1.039-0.119
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6210.551+0.070
TTM0.6410.554+0.087
YOY0.5950.479+0.116
5Y0.9200.622+0.298
10Y1.0390.674+0.365

2. Market Valuation of MedCap AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Medcap generates.

  • Above 15 is considered overpriced but always compare Medcap to the Medical Devices industry mean.
  • A PE ratio of 20.17 means the investor is paying kr20.17 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MedCap AB (publ):

  • The EOD is 25.217. Based on the earnings, the company is overpriced. -1
  • The MRQ is 20.167. Based on the earnings, the company is fair priced.
  • The TTM is 26.540. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD25.217MRQ20.167+5.049
MRQ20.167TTM26.540-6.372
TTM26.540YOY26.337+0.203
TTM26.5405Y34.025-7.485
5Y34.02510Y80.958-46.933
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD25.217-1.077+26.294
MRQ20.167-1.704+21.871
TTM26.540-2.081+28.621
YOY26.337-2.978+29.315
5Y34.025-2.379+36.404
10Y80.958-1.726+82.684
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MedCap AB (publ):

  • The EOD is 25.217. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.167. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.741. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD25.217MRQ20.167+5.049
MRQ20.167TTM23.741-3.573
TTM23.741YOY16.041+7.699
TTM23.7415Y27.225-3.485
5Y27.22510Y-10.637+37.862
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD25.217-0.932+26.149
MRQ20.167-1.578+21.745
TTM23.741-2.973+26.714
YOY16.041-6.318+22.359
5Y27.225-5.307+32.532
10Y-10.637-5.171-5.466
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medcap is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.89 means the investor is paying kr4.89 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of MedCap AB (publ):

  • The EOD is 6.108. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.885. Based on the equity, the company is fair priced.
  • The TTM is 4.379. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.108MRQ4.885+1.223
MRQ4.885TTM4.379+0.506
TTM4.379YOY3.572+0.807
TTM4.3795Y4.608-0.229
5Y4.60810Y3.045+1.563
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.1081.876+4.232
MRQ4.8852.372+2.513
TTM4.3792.434+1.945
YOY3.5723.217+0.355
5Y4.6083.893+0.715
10Y3.0454.245-1.200
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of MedCap AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.9612.773+7%2.718+9%2.530+17%1.372+116%
Book Value Per Share--69.08564.719+7%53.802+28%43.798+58%31.444+120%
Current Ratio--2.2312.270-2%2.177+2%1.758+27%1.589+40%
Debt To Asset Ratio--0.3820.389-2%0.372+3%0.458-17%0.489-22%
Debt To Equity Ratio--0.6210.641-3%0.595+4%0.920-33%1.039-40%
Dividend Per Share----0%-0%-0%-0%
Eps--4.1842.896+44%1.984+111%1.689+148%0.950+341%
Free Cash Flow Per Share--4.1843.172+32%0.697+500%1.407+197%0.742+464%
Free Cash Flow To Equity Per Share--2.7711.158+139%1.731+60%1.462+90%0.959+189%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--171.033--------
Intrinsic Value_10Y_min--92.371--------
Intrinsic Value_1Y_max--7.971--------
Intrinsic Value_1Y_min--4.062--------
Intrinsic Value_3Y_max--30.937--------
Intrinsic Value_3Y_min--16.776--------
Intrinsic Value_5Y_max--62.326--------
Intrinsic Value_5Y_min--34.402--------
Market Cap6248722800.000+20%5017672575.0004219053203.250+19%2847833205.000+76%2871165811.650+75%1645266795.375+205%
Net Profit Margin--0.1360.107+27%0.106+28%0.092+47%0.072+89%
Operating Margin--0.1660.143+17%0.155+7%0.130+28%0.104+60%
Operating Ratio--1.2760.970+31%0.862+48%0.901+42%0.915+39%
Pb Ratio6.108+20%4.8854.379+12%3.572+37%4.608+6%3.045+60%
Pe Ratio25.217+20%20.16726.540-24%26.337-23%34.025-41%80.958-75%
Price Per Share422.000+20%337.500284.000+19%192.325+75%193.715+74%111.018+204%
Price To Free Cash Flow Ratio25.217+20%20.16723.741-15%16.041+26%27.225-26%-10.637+153%
Price To Total Gains Ratio142.530+20%113.990111.865+2%74.719+53%204.109-44%192.803-41%
Quick Ratio--1.4241.486-4%1.4270%1.144+24%0.798+79%
Return On Assets--0.0370.027+38%0.023+63%0.020+83%0.012+215%
Return On Equity--0.0610.044+37%0.037+67%0.038+60%0.023+169%
Total Gains Per Share--2.9612.773+7%2.718+9%2.530+17%1.372+116%
Usd Book Value--94390490.00088354957.500+7%73214432.500+29%59656885.000+58%42816903.845+120%
Usd Book Value Change Per Share--0.2720.255+7%0.250+9%0.232+17%0.126+116%
Usd Book Value Per Share--6.3495.948+7%4.944+28%4.025+58%2.890+120%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.3840.266+44%0.182+111%0.155+148%0.087+341%
Usd Free Cash Flow--5716180.0004330787.500+32%948867.500+502%1917953.000+198%1011042.445+465%
Usd Free Cash Flow Per Share--0.3840.292+32%0.064+500%0.129+197%0.068+464%
Usd Free Cash Flow To Equity Per Share--0.2550.106+139%0.159+60%0.134+90%0.088+189%
Usd Market Cap574257625.320+20%461124109.643387730989.379+19%261715871.540+76%263860138.091+75%151200018.495+205%
Usd Price Per Share38.782+20%31.01626.100+19%17.675+75%17.802+74%10.203+204%
Usd Profit--5716180.0003953997.500+45%2701860.000+112%2300716.500+148%1235489.815+363%
Usd Revenue--41961540.00036470515.000+15%25532117.500+64%23844833.500+76%20829291.230+101%
Usd Total Gains Per Share--0.2720.255+7%0.250+9%0.232+17%0.126+116%
 EOD+4 -4MRQTTM+28 -5YOY+26 -75Y+29 -410Y+28 -5

3.2. Fundamental Score

Let's check the fundamental score of MedCap AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.217
Price to Book Ratio (EOD)Between0-16.108
Net Profit Margin (MRQ)Greater than00.136
Operating Margin (MRQ)Greater than00.166
Quick Ratio (MRQ)Greater than11.424
Current Ratio (MRQ)Greater than12.231
Debt to Asset Ratio (MRQ)Less than10.382
Debt to Equity Ratio (MRQ)Less than10.621
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.037
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of MedCap AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose423.000
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net -2,2001,100-1,100-300-1,400-1,000-2,4004,9002,500



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets1,662,200
Total Liabilities635,100
Total Stockholder Equity1,022,900
 As reported
Total Liabilities 635,100
Total Stockholder Equity+ 1,022,900
Total Assets = 1,662,200

Assets

Total Assets1,662,200
Total Current Assets765,200
Long-term Assets897,000
Total Current Assets
Cash And Cash Equivalents 188,200
Net Receivables 300,300
Inventory 276,700
Total Current Assets  (as reported)765,200
Total Current Assets  (calculated)765,200
+/-0
Long-term Assets
Property Plant Equipment 243,900
Goodwill 339,900
Intangible Assets 309,300
Long-term Assets Other 100
Long-term Assets  (as reported)897,000
Long-term Assets  (calculated)893,200
+/- 3,800

Liabilities & Shareholders' Equity

Total Current Liabilities343,000
Long-term Liabilities292,100
Total Stockholder Equity1,022,900
Total Current Liabilities
Short-term Debt 69,000
Short Long Term Debt 42,100
Accounts payable 227,300
Other Current Liabilities 37,400
Total Current Liabilities  (as reported)343,000
Total Current Liabilities  (calculated)375,800
+/- 32,800
Long-term Liabilities
Long term Debt 72,000
Capital Lease Obligations 147,200
Long-term Liabilities Other 28,700
Long-term Liabilities  (as reported)292,100
Long-term Liabilities  (calculated)247,900
+/- 44,200
Total Stockholder Equity
Common Stock5,923
Retained Earnings 576,000
Accumulated Other Comprehensive Income 12,700
Other Stockholders Equity 428,277
Total Stockholder Equity (as reported)1,022,900
Total Stockholder Equity (calculated)1,022,900
+/-0
Other
Capital Stock5,900
Cash and Short Term Investments 188,200
Common Stock Shares Outstanding 14,867
Current Deferred Revenue9,300
Liabilities and Stockholders Equity 1,662,200
Net Debt 73,000
Net Invested Capital 1,137,000
Net Working Capital 422,100
Property Plant and Equipment Gross 543,800
Short Long Term Debt Total 261,200



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-03-312007-12-31
> Total Assets 
0
195,537
199,071
200,602
0
0
295,982
304,842
298,744
306,841
296,563
310,028
302,344
304,160
308,758
310,701
306,315
335,877
328,713
364,758
506,620
524,178
522,118
601,010
551,070
551,283
535,363
549,156
535,128
528,529
555,844
636,727
640,367
628,417
562,273
563,165
538,847
616,804
600,200
661,575
655,000
665,600
668,900
798,800
793,800
781,500
842,300
930,000
1,092,700
1,042,000
1,081,300
1,111,200
1,082,800
1,128,800
1,169,500
1,208,800
1,219,600
1,221,600
1,429,300
1,483,600
1,545,600
1,602,400
1,662,200
1,662,2001,602,4001,545,6001,483,6001,429,3001,221,6001,219,6001,208,8001,169,5001,128,8001,082,8001,111,2001,081,3001,042,0001,092,700930,000842,300781,500793,800798,800668,900665,600655,000661,575600,200616,804538,847563,165562,273628,417640,367636,727555,844528,529535,128549,156535,363551,283551,070601,010522,118524,178506,620364,758328,713335,877306,315310,701308,758304,160302,344310,028296,563306,841298,744304,842295,98200200,602199,071195,5370
   > Total Current Assets 
0
67,779
74,250
76,209
0
0
121,883
131,685
124,443
132,273
120,456
134,712
124,783
125,891
132,061
133,224
139,239
166,873
164,647
177,687
306,206
315,674
318,171
392,933
341,817
343,804
331,552
345,286
330,625
330,775
351,646
392,014
396,152
383,966
318,745
306,746
286,723
349,443
337,100
314,226
308,700
293,500
298,500
258,300
257,900
249,900
282,000
300,200
482,900
442,700
426,900
452,500
448,600
448,200
474,900
506,100
515,600
529,700
741,800
696,700
752,600
738,100
765,200
765,200738,100752,600696,700741,800529,700515,600506,100474,900448,200448,600452,500426,900442,700482,900300,200282,000249,900257,900258,300298,500293,500308,700314,226337,100349,443286,723306,746318,745383,966396,152392,014351,646330,775330,625345,286331,552343,804341,817392,933318,171315,674306,206177,687164,647166,873139,239133,224132,061125,891124,783134,712120,456132,273124,443131,685121,8830076,20974,25067,7790
       Cash And Cash Equivalents 
0
8,498
14,517
14,275
0
0
21,512
29,423
33,109
25,010
28,074
30,309
18,359
16,849
22,690
28,038
30,285
43,000
48,714
45,521
43,641
39,984
28,096
21,222
72,145
69,735
69,113
75,341
72,886
56,794
62,706
50,937
45,925
40,338
26,340
42,588
31,314
73,126
61,300
40,616
45,200
46,800
56,600
15,700
18,200
16,800
20,600
25,100
209,500
171,400
146,500
142,300
137,900
132,500
139,700
167,600
144,400
173,000
236,200
213,800
223,300
193,900
188,200
188,200193,900223,300213,800236,200173,000144,400167,600139,700132,500137,900142,300146,500171,400209,50025,10020,60016,80018,20015,70056,60046,80045,20040,61661,30073,12631,31442,58826,34040,33845,92550,93762,70656,79472,88675,34169,11369,73572,14521,22228,09639,98443,64145,52148,71443,00030,28528,03822,69016,84918,35930,30928,07425,01033,10929,42321,5120014,27514,5178,4980
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63,025
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
155,547
130,400
126,695
144,798
0
143,237
140,100
134,600
117,500
124,900
119,200
115,600
138,300
156,200
150,300
142,400
130,600
157,300
170,800
165,300
177,000
177,000
209,000
188,000
199,400
252,400
283,000
277,300
300,300
300,300277,300283,000252,400199,400188,000209,000177,000177,000165,300170,800157,300130,600142,400150,300156,200138,300115,600119,200124,900117,500134,600140,100143,2370144,798126,695130,400155,547000000000000000063,02500000000000000000
       Other Current Assets 
0
30,876
30,496
34,593
0
0
46,690
51,663
38,936
52,514
40,916
48,940
41,791
50,354
51,773
49,989
48,805
-1
55,518
67,065
124,369
151,422
155,551
199,319
132,253
139,714
132,997
158,294
137,047
154,555
161,717
201,185
183,583
185,788
155,547
137,178
126,695
144,798
153,200
168,543
153,500
141,900
127,500
132,900
127,100
125,200
147,700
156,700
150,800
143,100
142,300
157,900
171,400
165,600
8,000
9,400
7,700
6,400
131,700
-100
100
66,600
17,400
17,40066,600100-100131,7006,4007,7009,4008,000165,600171,400157,900142,300143,100150,800156,700147,700125,200127,100132,900127,500141,900153,500168,543153,200144,798126,695137,178155,547185,788183,583201,185161,717154,555137,047158,294132,997139,714132,253199,319155,551151,422124,36967,06555,518-148,80549,98951,77350,35441,79148,94040,91652,51438,93651,66346,6900034,59330,49630,8760
   > Long-term Assets 
0
127,758
124,821
124,393
0
0
174,099
173,157
174,301
174,568
176,107
175,316
177,561
178,269
176,697
177,477
167,076
169,004
164,066
187,071
200,414
208,504
203,947
208,077
209,254
207,480
203,812
203,870
204,503
197,754
204,197
244,714
244,215
244,451
243,529
256,420
252,125
267,362
263,100
347,349
346,400
372,200
370,600
540,500
535,900
531,500
560,300
629,800
609,800
599,300
654,600
658,800
634,100
680,500
694,600
702,600
703,900
691,800
687,400
787,000
792,900
864,300
897,000
897,000864,300792,900787,000687,400691,800703,900702,600694,600680,500634,100658,800654,600599,300609,800629,800560,300531,500535,900540,500370,600372,200346,400347,349263,100267,362252,125256,420243,529244,451244,215244,714204,197197,754204,503203,870203,812207,480209,254208,077203,947208,504200,414187,071164,066169,004167,076177,477176,697178,269177,561175,316176,107174,568174,301173,157174,09900124,393124,821127,7580
       Property Plant Equipment 
0
31,489
27,718
27,175
0
0
27,773
27,049
26,061
25,524
24,822
23,903
23,686
24,403
25,398
25,282
25,168
16,181
16,128
18,329
20,659
28,666
27,927
27,002
27,604
26,722
25,391
24,662
24,267
23,343
22,733
35,645
34,191
32,899
35,844
36,758
37,535
38,498
47,800
49,982
49,900
55,700
54,600
218,500
213,300
209,700
203,700
196,300
188,000
183,200
192,800
188,600
187,200
238,300
253,700
263,200
255,700
248,500
242,600
256,000
256,900
250,900
243,900
243,900250,900256,900256,000242,600248,500255,700263,200253,700238,300187,200188,600192,800183,200188,000196,300203,700209,700213,300218,50054,60055,70049,90049,98247,80038,49837,53536,75835,84432,89934,19135,64522,73323,34324,26724,66225,39126,72227,60427,00227,92728,66620,65918,32916,12816,18125,16825,28225,39824,40323,68623,90324,82225,52426,06127,04927,7730027,17527,71831,4890
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,214
0
0
0
42,186
0
0
0
55,682
0
0
0
57,326
0
0
0
95,457
0
0
0
95,318
0
0
96,500
0
0
0
137,400
0
0
0
160,900
207,800
0
203,900
240,900
244,500
228,600
231,700
229,500
230,200
239,100
241,000
242,600
287,000
292,300
322,100
339,900
339,900322,100292,300287,000242,600241,000239,100230,200229,500231,700228,600244,500240,900203,9000207,800160,900000137,40000096,5000095,31800095,45700057,32600055,68200042,18600033,214000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,252
0
1,000
0
0
0
1,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,7000001,00001,252000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
116,534
0
0
0
125,684
0
0
0
120,046
0
0
0
116,518
0
0
0
108,830
0
0
202,807
117,655
209,520
224,106
114,800
292,862
291,300
310,700
175,100
318,700
318,400
318,400
191,500
221,500
417,700
208,600
217,500
220,000
212,300
204,100
208,400
205,600
205,400
199,300
198,800
238,800
238,300
285,400
309,300
309,300285,400238,300238,800198,800199,300205,400205,600208,400204,100212,300220,000217,500208,600417,700221,500191,500318,400318,400318,700175,100310,700291,300292,862114,800224,106209,520117,655202,80700108,830000116,518000120,046000125,684000116,534000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
-1
0
0
0
1
-1
0
0
-1
-1
-1
-1
0
4,505
-100
-100
-200
3,300
4,200
100
45,000
4,200
4,100
3,600
-200
-100
100
100
39,300
100
100
100
100
-100
100
5,500
0
05,500100-10010010010010039,300100100-100-2003,6004,1004,20045,0001004,2003,300-200-100-1004,5050-1-1-1-100-11000-1-1-1000000000000000000000000
> Total Liabilities 
0
68,098
67,680
66,489
0
0
128,191
134,904
125,382
129,145
120,337
130,040
146,747
144,422
149,046
140,882
130,059
140,962
134,430
169,276
306,978
319,605
311,864
379,087
276,280
280,860
265,316
268,523
253,361
241,308
265,606
328,574
331,451
319,088
273,028
270,879
244,126
333,388
332,500
380,881
371,400
381,200
395,100
502,100
481,200
456,400
509,500
583,700
514,100
450,400
479,300
499,200
468,800
487,600
471,800
463,600
449,200
409,200
570,600
597,900
595,400
619,700
635,100
635,100619,700595,400597,900570,600409,200449,200463,600471,800487,600468,800499,200479,300450,400514,100583,700509,500456,400481,200502,100395,100381,200371,400380,881332,500333,388244,126270,879273,028319,088331,451328,574265,606241,308253,361268,523265,316280,860276,280379,087311,864319,605306,978169,276134,430140,962130,059140,882149,046144,422146,747130,040120,337129,145125,382134,904128,1910066,48967,68068,0980
   > Total Current Liabilities 
0
35,702
36,503
38,274
0
0
63,127
67,713
60,594
66,667
59,764
75,097
85,298
83,711
92,668
89,442
83,985
98,522
94,863
115,398
244,687
253,567
252,282
323,271
223,536
236,821
226,012
231,188
187,857
179,149
198,610
251,234
256,864
275,274
230,701
236,199
211,361
249,664
256,800
260,005
256,200
250,500
281,900
258,500
250,300
246,100
304,300
322,000
275,700
246,700
260,500
268,500
249,600
244,900
242,000
261,600
256,000
230,200
302,000
315,400
322,500
319,900
343,000
343,000319,900322,500315,400302,000230,200256,000261,600242,000244,900249,600268,500260,500246,700275,700322,000304,300246,100250,300258,500281,900250,500256,200260,005256,800249,664211,361236,199230,701275,274256,864251,234198,610179,149187,857231,188226,012236,821223,536323,271252,282253,567244,687115,39894,86398,52283,98589,44292,66883,71185,29875,09759,76466,66760,59467,71363,1270038,27436,50335,7020
       Short-term Debt 
0
7,579
4,740
4,991
0
0
14,008
9,963
17,402
13,296
12,535
11,500
25,337
23,611
29,564
27,044
29,304
27,029
32,475
45,570
144,336
142,995
150,720
162,531
114,543
120,136
112,815
129,366
96,640
82,292
96,364
122,545
125,399
143,553
122,602
119,232
107,856
123,757
126,600
103,884
116,300
130,700
136,800
104,000
115,500
124,800
166,500
173,800
112,200
108,200
106,600
103,100
101,600
89,900
91,500
93,800
83,100
88,300
116,100
93,600
85,600
81,600
69,000
69,00081,60085,60093,600116,10088,30083,10093,80091,50089,900101,600103,100106,600108,200112,200173,800166,500124,800115,500104,000136,800130,700116,300103,884126,600123,757107,856119,232122,602143,553125,399122,54596,36482,29296,640129,366112,815120,136114,543162,531150,720142,995144,33645,57032,47527,02929,30427,04429,56423,61125,33711,50012,53513,29617,4029,96314,008004,9914,7407,5790
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135,414
138,225
107,856
123,757
0
103,884
116,300
130,700
22,400
79,300
90,700
99,900
140,200
147,700
87,100
83,400
80,000
75,900
74,100
64,200
67,000
67,300
56,400
60,100
88,200
58,000
52,400
52,000
42,100
42,10052,00052,40058,00088,20060,10056,40067,30067,00064,20074,10075,90080,00083,40087,100147,700140,20099,90090,70079,30022,400130,700116,300103,8840123,757107,856138,225135,4140000000000000000000000000000000000
       Accounts payable 
0
14,018
34,454
18,888
0
0
40,746
21,824
36,175
45,759
39,531
25,370
48,117
48,516
52,009
26,484
44,401
5,556
48,458
25,880
90,575
99,219
90,472
85,928
102,625
107,285
105,422
52,216
89,234
93,347
95,015
69,113
125,456
125,941
101,236
52,018
99,098
119,725
70,200
128,702
120,400
100,600
74,900
136,400
120,800
106,200
52,100
139,000
152,700
129,200
54,700
152,600
134,000
139,900
50,000
156,000
161,800
124,900
75,800
196,200
205,300
198,800
227,300
227,300198,800205,300196,20075,800124,900161,800156,00050,000139,900134,000152,60054,700129,200152,700139,00052,100106,200120,800136,40074,900100,600120,400128,70270,200119,72599,09852,018101,236125,941125,45669,11395,01593,34789,23452,216105,422107,285102,62585,92890,47299,21990,57525,88048,4585,55644,40126,48452,00948,51648,11725,37039,53145,75936,17521,82440,7460018,88834,45414,0180
       Other Current Liabilities 
0
4,672
-2,691
4,563
0
0
8,373
9,802
7,017
7,612
7,698
7,146
11,844
11,584
11,095
12,223
10,280
50,011
13,930
15,099
9,776
11,353
11,090
36,401
6,368
9,400
7,775
16,523
1,983
3,510
7,231
18,035
-1
-1
6,863
19,313
1
6,182
19,200
-18,347
-8,700
-6,600
18,000
-8,000
-4,800
-3,800
26,300
-2,800
10,800
9,300
45,800
12,800
14,000
15,100
36,800
11,800
11,100
17,000
110,000
25,600
31,600
39,500
37,400
37,40039,50031,60025,600110,00017,00011,10011,80036,80015,10014,00012,80045,8009,30010,800-2,80026,300-3,800-4,800-8,00018,000-6,600-8,700-18,34719,2006,182119,3136,863-1-118,0357,2313,5101,98316,5237,7759,4006,36836,40111,09011,3539,77615,09913,93050,01110,28012,22311,09511,58411,8447,1467,6987,6127,0179,8028,373004,563-2,6914,6720
   > Long-term Liabilities 
0
32,396
31,177
28,215
0
0
65,064
67,191
64,788
62,478
60,573
54,943
61,449
60,711
56,378
51,440
46,074
42,440
39,567
53,878
62,291
66,038
59,582
55,816
52,744
44,039
39,304
37,335
65,504
62,159
66,996
77,340
74,587
43,814
42,327
34,680
32,765
83,724
75,700
120,876
115,200
130,700
113,200
243,600
230,900
210,300
205,200
261,700
238,400
203,700
218,800
230,700
219,200
242,700
229,800
202,000
193,200
179,000
268,600
282,500
272,900
299,800
292,100
292,100299,800272,900282,500268,600179,000193,200202,000229,800242,700219,200230,700218,800203,700238,400261,700205,200210,300230,900243,600113,200130,700115,200120,87675,70083,72432,76534,68042,32743,81474,58777,34066,99662,15965,50437,33539,30444,03952,74455,81659,58266,03862,29153,87839,56742,44046,07451,44056,37860,71161,44954,94360,57362,47864,78867,19165,0640028,21531,17732,3960
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
164,400
157,100
145,900
133,000
176,600
165,400
159,300
149,500
136,500
223,900
219,900
212,200
209,700
0
0209,700212,200219,900223,900136,500149,500159,300165,400176,600133,000145,900157,100164,4000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,515
15,687
22,979
36,003
0
34,892
35,000
52,600
48,500
44,900
43,900
40,200
46,700
54,700
48,300
39,300
61,600
84,800
86,200
66,100
64,500
42,700
43,700
42,500
44,600
62,700
60,800
0
0
0060,80062,70044,60042,50043,70042,70064,50066,10086,20084,80061,60039,30048,30054,70046,70040,20043,90044,90048,50052,60035,00034,892036,00322,97915,68729,5150000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,433
0
0
0
0
0
0
45,700
0
0
0
40,700
0
0
0
38,100
0
0
0
36,300
0
0
0
0
0
0
0
0
0000000036,30000038,10000040,70000045,70000000037,43300000000000000000000000000000000000
> Total Stockholder Equity
0
127,439
124,614
127,553
0
0
151,000
137,995
140,967
145,856
145,976
148,781
153,487
156,760
156,674
160,255
166,904
183,227
182,118
185,224
191,078
193,729
199,008
209,000
261,355
258,903
258,633
266,796
267,631
272,015
274,158
281,788
282,945
283,597
268,916
270,895
273,248
275,418
264,800
276,789
279,400
280,000
271,300
293,200
308,200
320,500
327,800
340,800
573,100
585,800
595,700
604,600
612,300
639,400
696,000
743,400
768,400
810,300
856,300
880,200
947,600
977,500
1,022,900
1,022,900977,500947,600880,200856,300810,300768,400743,400696,000639,400612,300604,600595,700585,800573,100340,800327,800320,500308,200293,200271,300280,000279,400276,789264,800275,418273,248270,895268,916283,597282,945281,788274,158272,015267,631266,796258,633258,903261,355209,000199,008193,729191,078185,224182,118183,227166,904160,255156,674156,760153,487148,781145,976145,856140,967137,995151,00000127,553124,614127,4390
   Common Stock
0
4,650
0
4,650
0
0
0
4,650
0
0
0
4,650
0
0
0
4,650
0
0
0
4,846
0
0
0
4,846
0
0
0
5,360
0
0
0
5,360
0
0
268,916
5,360
273,248
275,418
5,400
276,789
279,400
280,000
5,400
293,200
308,200
320,500
5,400
340,800
573,100
585,800
5,900
604,600
612,300
639,400
5,900
743,400
5,923
5,923
5,900
5,923
5,923
5,923
5,923
5,9235,9235,9235,9235,9005,9235,923743,4005,900639,400612,300604,6005,900585,800573,100340,8005,400320,500308,200293,2005,400280,000279,400276,7895,400275,418273,2485,360268,916005,3600005,3600004,8460004,8460004,6500004,6500004,6500004,65004,6500
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,100
0
941,678
971,578
12,700
12,700971,578941,678020,1000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
157,532
124,614
157,532
0
0
151,000
157,532
140,967
145,856
145,976
157,532
153,487
156,760
156,674
156,255
166,904
183,227
182,118
167,118
191,078
193,729
199,008
165,962
261,355
258,903
258,633
217,201
267,631
272,015
274,158
212,256
282,945
283,597
268,916
217,973
273,248
275,418
222,600
276,789
279,400
280,000
233,900
293,200
308,200
320,500
208,200
340,800
573,100
585,800
412,400
604,600
612,300
639,400
427,900
743,400
762,477
804,377
428,300
874,277
-1
-1
428,277
428,277-1-1874,277428,300804,377762,477743,400427,900639,400612,300604,600412,400585,800573,100340,800208,200320,500308,200293,200233,900280,000279,400276,789222,600275,418273,248217,973268,916283,597282,945212,256274,158272,015267,631217,201258,633258,903261,355165,962199,008193,729191,078167,118182,118183,227166,904156,255156,674156,760153,487157,532145,976145,856140,967157,532151,00000157,532124,614157,5320



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,587,400
Cost of Revenue-1,365,900
Gross Profit221,500221,500
 
Operating Income (+$)
Gross Profit221,500
Operating Expense-711,300
Operating Income221,500-489,800
 
Operating Expense (+$)
Research Development45,000
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense711,30045,000
 
Net Interest Income (+$)
Interest Income8,000
Interest Expense-15,600
Other Finance Cost-5,300
Net Interest Income-2,300
 
Pretax Income (+$)
Operating Income221,500
Net Interest Income-2,300
Other Non-Operating Income Expenses0
Income Before Tax (EBT)222,300220,700
EBIT - interestExpense = 205,900
222,000
187,800
Interest Expense15,600
Earnings Before Interest and Taxes (EBIT)221,500237,900
Earnings Before Interest and Taxes (EBITDA)325,600
 
After tax Income (+$)
Income Before Tax222,300
Tax Provision-42,100
Net Income From Continuing Ops150,600180,200
Net Income172,200
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,365,900
Total Other Income/Expenses Net8002,300
 

Technical Analysis of Medcap
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medcap. The general trend of Medcap is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medcap's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MedCap AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 424.00.

The bearish price targets are: 358.00 > 349.50 > 330.00.

Tweet this
MedCap AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MedCap AB (publ). The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MedCap AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MedCap AB (publ).

MedCap AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartMedCap AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MedCap AB (publ). The current adx is .

MedCap AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MedCap AB (publ).

MedCap AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MedCap AB (publ).

MedCap AB (publ) Daily Relative Strength Index (RSI) ChartMedCap AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MedCap AB (publ).

MedCap AB (publ) Daily Stochastic Oscillator ChartMedCap AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MedCap AB (publ).

MedCap AB (publ) Daily Commodity Channel Index (CCI) ChartMedCap AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MedCap AB (publ).

MedCap AB (publ) Daily Chande Momentum Oscillator (CMO) ChartMedCap AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MedCap AB (publ).

MedCap AB (publ) Daily Williams %R ChartMedCap AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MedCap AB (publ).

MedCap AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MedCap AB (publ).

MedCap AB (publ) Daily Average True Range (ATR) ChartMedCap AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MedCap AB (publ).

MedCap AB (publ) Daily On-Balance Volume (OBV) ChartMedCap AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MedCap AB (publ).

MedCap AB (publ) Daily Money Flow Index (MFI) ChartMedCap AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MedCap AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

MedCap AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MedCap AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose423.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medcap with someone you think should read this too:
  • Are you bullish or bearish on Medcap? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medcap? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MedCap AB (publ)

I send you an email if I find something interesting about MedCap AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about MedCap AB (publ).

Receive notifications about MedCap AB (publ) in your mailbox!